Financial Performance Expectations - The company expects a net loss of between 60 million and 75 million yuan for the year 2024, compared to a profit of 84.63 million yuan in the same period last year[3]. - The projected operating revenue for 2024 is between 3.4 billion and 3.6 billion yuan, an increase from 2.54 billion yuan in the previous year[3]. - The impact of non-recurring gains and losses on net profit is estimated to be approximately 2.81 million yuan, down from 3.62 million yuan in the previous year[6]. Operational Challenges - The decline in performance is primarily due to intensified competition in the ACM product series, leading to lower sales prices and increased costs from ongoing projects[5]. - The company is undergoing trial production for several projects, including a 200,000-ton ACM facility and a 200,000-ton caustic soda technology upgrade, which have contributed to rising costs[5]. Investor Guidance - The specific financial data for the 2024 fiscal year will be detailed in the annual report, urging investors to make cautious decisions[7].
日科化学(300214) - 2024 Q4 - 年度业绩预告